Sage Mountain Advisors LLC Takes Position in Agilent Technologies, Inc. $A

Key Points

• Sage Mountain Advisors LLC acquired 3,451 shares of Agilent Technologies, valued at approximately $407,000, highlighting growing institutional interest in the company.
• Agilent Technologies reported earnings of $1.37 per share for the last quarter, matching expectations, with a year-over-year revenue increase of 10.1%.
• The company announced a quarterly dividend of $0.248 per share, reflecting an annualized yield of 0.7%.

Sage Mountain Advisors LLC acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 3,451 shares of the medical research company's stock, valued at approximately $407,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its holdings in shares of Agilent Technologies by 0.7% during the first quarter. Vanguard Group Inc. now owns 33,408,626 shares of the medical research company's stock worth $3,908,141,000 after buying an additional 240,965 shares in the last quarter. Pictet Asset Management Holding SA grew its stake in Agilent Technologies by 2.5% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,341,870 shares of the medical research company's stock worth $624,888,000 after acquiring an additional 128,131 shares during the period. Generation Investment Management LLP raised its holdings in Agilent Technologies by 19.8% in the 1st quarter. Generation Investment Management LLP now owns 4,983,556 shares of the medical research company's stock valued at $582,976,000 after acquiring an additional 824,243 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Agilent Technologies by 18.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,836,105 shares of the medical research company's stock valued at $448,748,000 after acquiring an additional 604,124 shares during the last quarter. Finally, Nordea Investment Management AB lifted its stake in shares of Agilent Technologies by 16.2% during the 2nd quarter. Nordea Investment Management AB now owns 3,213,748 shares of the medical research company's stock worth $383,143,000 after purchasing an additional 447,207 shares during the period.

Agilent Technologies Trading Up 0.4%

NYSE A opened at $148.03 on Friday. The firm has a market capitalization of $41.97 billion, a price-to-earnings ratio of 34.75, a PEG ratio of 4.83 and a beta of 1.26. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. Agilent Technologies, Inc. has a one year low of $96.43 and a one year high of $153.84. The company's 50 day moving average price is $130.39 and its 200 day moving average price is $119.34.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period in the previous year, the firm earned $1.32 earnings per share. Agilent Technologies's revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th were paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, September 30th. Agilent Technologies's payout ratio is currently 23.24%.

Analyst Ratings Changes

Several research firms recently weighed in on A. JPMorgan Chase & Co. increased their target price on Agilent Technologies from $155.00 to $165.00 and gave the stock an "overweight" rating in a research report on Thursday, October 9th. Rothschild Redb upgraded shares of Agilent Technologies to a "strong-buy" rating in a report on Wednesday, October 8th. UBS Group raised shares of Agilent Technologies from a "neutral" rating to a "buy" rating and raised their target price for the stock from $130.00 to $170.00 in a research report on Wednesday, October 8th. Evercore ISI upped their price target on shares of Agilent Technologies from $128.00 to $140.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 7th. Finally, Wall Street Zen raised shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research note on Friday, October 3rd. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $149.62.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.